| Year |
Citation |
Score |
| 2023 |
Neubert EN, DeRogatis JM, Lewis SA, Viramontes KM, Ortega P, Henriquez ML, Buisson R, Messaoudi I, Tinoco R. HMGB2 regulates the differentiation and stemness of exhausted CD8 T cells during chronic viral infection and cancer. Nature Communications. 14: 5631. PMID 37704621 DOI: 10.1038/s41467-023-41352-0 |
0.585 |
|
| 2023 |
Hope JL, Otero DC, Bae EA, Stairiker CJ, Palete AB, Faso HA, Lin M, Henriquez ML, Roy S, Seo H, Lei X, Wang ES, Chow S, Tinoco R, Daniels GA, et al. PSGL-1 attenuates early TCR signaling to suppress CD8 T cell progenitor differentiation and elicit terminal CD8 T cell exhaustion. Cell Reports. 42: 112436. PMID 37115668 DOI: 10.1016/j.celrep.2023.112436 |
0.773 |
|
| 2023 |
DeRogatis JM, Neubert EN, Viramontes KM, Henriquez ML, Nicholas DA, Tinoco R. Cell-Intrinsic CD38 Expression Sustains Exhausted CD8 T Cells by Regulating Their Survival and Metabolism during Chronic Viral Infection. Journal of Virology. e0022523. PMID 37039663 DOI: 10.1128/jvi.00225-23 |
0.504 |
|
| 2022 |
Viramontes KM, Neubert EN, DeRogatis JM, Tinoco R. PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells. Frontiers in Immunology. 13: 869768. PMID 35774790 DOI: 10.3389/fimmu.2022.869768 |
0.618 |
|
| 2022 |
DeRogatis JM, Viramontes KM, Neubert EN, Henriquez ML, Guerrero-Juarez CF, Tinoco R. Targeting the PSGL-1 Immune Checkpoint Promotes Immunity to PD-1 Resistant Melanoma. Cancer Immunology Research. PMID 35303066 DOI: 10.1158/2326-6066.CIR-21-0690 |
0.406 |
|
| 2021 |
Tinoco R, Neubert EN, Stairiker CJ, Henriquez ML, Bradley LM. PSGL-1 Is a T Cell Intrinsic Inhibitor That Regulates Effector and Memory Differentiation and Responses During Viral Infection. Frontiers in Immunology. 12: 677824. PMID 34326837 DOI: 10.3389/fimmu.2021.677824 |
0.729 |
|
| 2021 |
DeRogatis JM, Viramontes KM, Neubert EN, Tinoco R. PSGL-1 Immune Checkpoint Inhibition for CD4 T Cell Cancer Immunotherapy. Frontiers in Immunology. 12: 636238. PMID 33708224 DOI: 10.3389/fimmu.2021.636238 |
0.589 |
|
| 2020 |
Li Y, Elmén L, Segota I, Xian Y, Tinoco R, Feng Y, Fujita Y, Segura Muñoz RR, Schmaltz R, Bradley LM, Ramer-Tait A, Zarecki R, Long T, Peterson SN, Ronai ZA. Prebiotic-Induced Anti-tumor Immunity Attenuates Tumor Growth. Cell Reports. 30: 1753-1766.e6. PMID 32049008 DOI: 10.1016/J.Celrep.2020.01.035 |
0.584 |
|
| 2020 |
Scortegagna M, Hockemeyer K, Dolgalev I, Poźniak J, Rambow F, Li Y, Feng Y, Tinoco R, Otero DC, Zhang T, Brown K, Bosenberg M, Bradley LM, Marine JC, Aifantis I, et al. Siah2 control of T-regulatory cells limits anti-tumor immunity. Nature Communications. 11: 99. PMID 31911617 DOI: 10.1038/S41467-019-13826-7 |
0.674 |
|
| 2019 |
Li Y, Tinoco R, Elmén L, Segota I, Xian Y, Fujita Y, Sahu A, Zarecki R, Marie K, Feng Y, Khateb A, Frederick DT, Ashkenazi SK, Kim H, Perez EG, et al. Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5 mice. Nature Communications. 10: 1492. PMID 30940817 DOI: 10.1038/S41467-019-09525-Y |
0.734 |
|
| 2018 |
Fujita Y, Khateb A, Li Y, Tinoco R, Zhang T, Bar-Yoseph H, Tam MA, Chowers Y, Sabo E, Gerassy-Vainberg S, Starosvetsky E, James B, Brown K, Shen-Orr SS, Bradley LM, et al. Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of Colitis. Cell Reports. 24: 3296-3311.e6. PMID 30232010 DOI: 10.1016/j.celrep.2018.08.057 |
0.599 |
|
| 2018 |
Borlido J, Sakuma S, Raices M, Carrette F, Tinoco R, Bradley LM, D'Angelo MA. Nuclear pore complex-mediated modulation of TCR signaling is required for naïve CD4 T cell homeostasis. Nature Immunology. PMID 29736031 DOI: 10.1038/S41590-018-0103-5 |
0.796 |
|
| 2018 |
Tinoco R, Carrette F, Henriquez ML, Fujita Y, Bradley LM. Fucosyltransferase Induction during Influenza Virus Infection Is Required for the Generation of Functional Memory CD4T Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 29491007 DOI: 10.4049/Jimmunol.1701251 |
0.763 |
|
| 2017 |
Tinoco R, Bradley LM. Targeting the PSGL-1 pathway for immune modulation. Immunotherapy. 9: 785-788. PMID 28877633 DOI: 10.2217/Imt-2017-0078 |
0.595 |
|
| 2017 |
Tinoco R, Otero DC, Takahashi AA, Bradley LM. PSGL-1: A New Player in the Immune Checkpoint Landscape. Trends in Immunology. PMID 28262471 DOI: 10.1016/J.It.2017.02.002 |
0.751 |
|
| 2016 |
Tinoco R, Carrette F, Barraza ML, Otero DC, Magaña J, Bosenberg MW, Swain SL, Bradley LM. PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion. Immunity. 44: 1470. PMID 27332735 DOI: 10.1016/J.Immuni.2016.05.011 |
0.781 |
|
| 2016 |
Tinoco R, Carrette F, Barraza ML, Otero DC, Magaña J, Bosenberg MW, Swain SL, Bradley LM. PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion. Immunity. 44: 1190-203. PMID 27192578 DOI: 10.1016/J.Immuni.2016.04.015 |
0.8 |
|
| 2012 |
Baaten BJ, Tinoco R, Chen AT, Bradley LM. Regulation of Antigen-Experienced T Cells: Lessons from the Quintessential Memory Marker CD44. Frontiers in Immunology. 3: 23. PMID 22566907 DOI: 10.3389/Fimmu.2012.00023 |
0.795 |
|
| 2009 |
Tinoco R, Alcalde V, Yang Y, Sauer K, Zuniga EI. Cell-intrinsic transforming growth factor-beta signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo. Immunity. 31: 145-57. PMID 19604493 DOI: 10.1016/J.Immuni.2009.06.015 |
0.742 |
|
| 2009 |
Kerdiles YM, Beisner DR, Tinoco R, Dejean AS, Castrillon DH, DePinho RA, Hedrick SM. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nature Immunology. 10: 176-84. PMID 19136962 DOI: 10.1038/Ni.1689 |
0.511 |
|
| Show low-probability matches. |